Promising clinical and pathological response rates with neoadjuvant sequential doxorubicine (DOX) and docetaxel (DOC) in locally advanced breast cancer (LABC)

Details

Language :

English

ISSN :

09598049

Volume :

38

Database :

Academic Search Index

Journal :

European Journal of Cancer

Publication Type :

Academic Journal

Accession number :

7832593

Full Text :

https://doi.org/10.1016/s0959-8049(02)80194-0